Skip to content

Neural mechanisms of closed-loop iTBS in improving cognitive function in depression by modulating the prefrontal-hippocampal circuit

Neural mechanisms of closed-loop iTBS in improving cognitive function in depression by modulating the prefrontal-hippocampal circuit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126149
Enrollment
Unknown
Registered
2026-06-04
Start date
2026-06-14
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Interventions

iTBS Stimulation Group 1:single-iTBS
iTBS Sham Stimulation Group 1:single-iTBS was administered using a sham stimulation coil.
Healthy Control:None
closed-loop iTBS Group:Closed-loop iTBS
iTBS Group2:iTBS
iTBS Sham Stimulation Group 2:iTBS was administered using a sham stimulation coil.
Depression Group:None

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Age 12–60 years, regardless of gender; 2. Diagnosis meets the diagnostic criteria for depression according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V); 3. HAMD-17 score >= 17; 4. Able to cooperate in completing the study-related questionnaires, assessments, examinations, and treatments; 5. The patient and their family fully understand the study procedures and content and agree to participate; both the patient and their family must sign the informed consent form. Inclusion Criteria for Healthy Controls: 1. No history of serious physical illness, head trauma, or neurological disease; 2. HAMD-17 score < 7; 3. No history of psychiatric episodes and no family history of mental disorders; 4. The participant and their family fully understand the study procedures and content and agree to participate; both the participant and their family must sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other severe systemic diseases (including severe cardiac, renal, and hepatic diseases); 2. Diagnosis of other severe psychotic symptoms, presence of suicidal ideation, self-harm, or suicidal behavior; 3. Individuals with alcohol or drug dependence; 4. Individuals with intellectual disability; 5. Individuals with metal implants in the body, such as pacemakers or intracranial electrodes, who have contraindications for MRI and iTBS; 6. Individuals who have received iTBS or MECT treatment within the past 6 months.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale (HAMD/HAM-D);Patient Health Questionnaire-9 (PHQ-9);Social cognitive task;EEG and its associated parameters;fNIRS related indicators;MRI related-indicators;HRV;

Secondary

MeasureTime frame
Clinical Global Impression Scale (CGI);Repeatable Battery for the Assessment of Neuropsychological Status, RBANS;Questionnaire for Assessing the Integrity of Blinding;Hamilton Anxiety Scale (HAMA);Athens Insomnia Scale (AIS);IMS-12;Mood VAS;Generalized Anxiety Disorder 7-item (GAD-7);

Countries

China

Contacts

Public ContactShen Yanmei

The Second Xiangya Hospital of Central South University

ymshen@csu.edu.cn+86 151 1626 9263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026